The Latest Epilepsy Research

CURE Epilepsy is dedicated to funding patient-focused research to find a cure for the 65 million people with epilepsy worldwide. This month, we share the following articles and abstracts which are furthering the study of epilepsy and bringing the world closer to a cure.

This issue of Epilepsy Research News includes summaries of articles on:

  • Could Blood Pressure Meds Help Prevent Adult-Onset Epilepsy?

  • Tail of Hippocampus May be Hub for Seizures in Mice and People

  • The Power of Big Data in Epilepsy Research: ILAE Sharp Waves Podcast

Could Blood Pressure Meds Help Prevent Adult-Onset Epilepsy?


A class of blood pressure medications, called angiotensin receptor blockers (ARBs), appear to help lower seniors' risk of developing epilepsy, a new study finds. Overall, people taking ARBs had a 20% to 30% lower risk of developing epilepsy compared with people taking other blood pressure medications.

Tail of Hippocampus May be Hub for Seizures in Mice and People


Dr. Quynh Anh Nguyen, assistant professor of pharmacology at Vanderbilt University, found that the stem of the hippocampus may play a role in epilepsy. Dr. Nguyen's study showed the activation in a tiny posterior part of the hippocampus called the fasciola cinereum. Despite the subregion’s obscurity, it looked to be an important and previously overlooked contributor to epilepsy in people who do not respond to anti-seizure medications or tissue ablation in the hippocampus.

The Power of Big Data in Epilepsy Research: ILAE Sharp Waves Podcast


Dr. Philippe Ryvlin of the University Hospital of Lausanne, Switzerland, discusses the Human Intracerebral EEG Platform, which is a cloud-based, collaborative environment that encourages the sharing of data and the conducting of research with state-of-the-art methodologies and software. This platform has the potential to drive epilepsy research forward, specifically in the areas of biomarker identification and the use of a virtual brain to inform surgery decisions.

Check Out Our Latest:

Our mission is to find a cure for epilepsy, by promoting and funding patient-focused research.

CURE Epilepsy is a non-profit 501(c)(3) tax-exempt organization. Our tax identification number is 36-4253176.